Cargando…

Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience

INTRODUCTION: COVID-19 has disrupted the provision of breast reconstructive services throughout the UK. Autologous free flap breast reconstruction was restarted in our unit on 3 June 2020. We aimed to compare the unit's performance of microsurgical autologous breast reconstruction in the “post-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Weiguang, Köhler, Guido, Haywood, Richard M, Rosich-Medina, Anais, Masud, Dhalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496956/
https://www.ncbi.nlm.nih.gov/pubmed/34756656
http://dx.doi.org/10.1016/j.bjps.2021.09.007
_version_ 1784579858462932992
author Ho, Weiguang
Köhler, Guido
Haywood, Richard M
Rosich-Medina, Anais
Masud, Dhalia
author_facet Ho, Weiguang
Köhler, Guido
Haywood, Richard M
Rosich-Medina, Anais
Masud, Dhalia
author_sort Ho, Weiguang
collection PubMed
description INTRODUCTION: COVID-19 has disrupted the provision of breast reconstructive services throughout the UK. Autologous free flap breast reconstruction was restarted in our unit on 3 June 2020. We aimed to compare the unit's performance of microsurgical autologous breast reconstruction in the “post-COVID” period compared with the exact time period in the preceding year. METHODS: We retrospectively reviewed prospectively collected data in the “pre-COVID” (from 3 June 2019 to 31 December 2019) and “post-COVID” period (from 3 June 2020 to 31 December 2020). Patient demographics included age, body mass index, co-morbidities, Anaesthesiologists (ASA) grade and smoking status. Surgical factors included neoadjuvant chemotherapy, previous chest wall radiotherapy, unilateral or bilateral reconstruction, reconstruction timing, number of pedicles, contralateral symmetrisation and other procedures. dependant variables were ischaemic time, operative time, mastectomy weight, flap weight, length of stay, return to theatre and complication rates. The number of trainers and trainees present in theatre was recorded and analysed. RESULTS: Fewer DIEP flaps were performed in the “post-COVID” period (45 vs. 29). No significant difference was observed in mastectomy resection weight, but flap weight was significantly increased. No significant difference was found in ischaemic time as well. The postoperative length of stay was significantly reduced. No significant difference was found in rates of return to theatre, unplanned admission, infection, haematoma, seroma or wound dehiscence. No cases of venous thromboembolism or flap failures were recorded. The mean number of trainers and trainees, and the trainee-to-trainer ratio was not found to be significantly different between cohorts. CONCLUSION: Although fewer cases were performed, autologous breast reconstruction was safely delivered throughout the COVID-19 pandemic in the first wave without affecting training.
format Online
Article
Text
id pubmed-8496956
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84969562021-10-08 Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience Ho, Weiguang Köhler, Guido Haywood, Richard M Rosich-Medina, Anais Masud, Dhalia J Plast Reconstr Aesthet Surg Article INTRODUCTION: COVID-19 has disrupted the provision of breast reconstructive services throughout the UK. Autologous free flap breast reconstruction was restarted in our unit on 3 June 2020. We aimed to compare the unit's performance of microsurgical autologous breast reconstruction in the “post-COVID” period compared with the exact time period in the preceding year. METHODS: We retrospectively reviewed prospectively collected data in the “pre-COVID” (from 3 June 2019 to 31 December 2019) and “post-COVID” period (from 3 June 2020 to 31 December 2020). Patient demographics included age, body mass index, co-morbidities, Anaesthesiologists (ASA) grade and smoking status. Surgical factors included neoadjuvant chemotherapy, previous chest wall radiotherapy, unilateral or bilateral reconstruction, reconstruction timing, number of pedicles, contralateral symmetrisation and other procedures. dependant variables were ischaemic time, operative time, mastectomy weight, flap weight, length of stay, return to theatre and complication rates. The number of trainers and trainees present in theatre was recorded and analysed. RESULTS: Fewer DIEP flaps were performed in the “post-COVID” period (45 vs. 29). No significant difference was observed in mastectomy resection weight, but flap weight was significantly increased. No significant difference was found in ischaemic time as well. The postoperative length of stay was significantly reduced. No significant difference was found in rates of return to theatre, unplanned admission, infection, haematoma, seroma or wound dehiscence. No cases of venous thromboembolism or flap failures were recorded. The mean number of trainers and trainees, and the trainee-to-trainer ratio was not found to be significantly different between cohorts. CONCLUSION: Although fewer cases were performed, autologous breast reconstruction was safely delivered throughout the COVID-19 pandemic in the first wave without affecting training. British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. 2022-01 2021-10-07 /pmc/articles/PMC8496956/ /pubmed/34756656 http://dx.doi.org/10.1016/j.bjps.2021.09.007 Text en © 2021 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ho, Weiguang
Köhler, Guido
Haywood, Richard M
Rosich-Medina, Anais
Masud, Dhalia
Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience
title Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience
title_full Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience
title_fullStr Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience
title_full_unstemmed Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience
title_short Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience
title_sort microsurgical autologous breast reconstruction in the midst of a pandemic: a single-unit covid-19 experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496956/
https://www.ncbi.nlm.nih.gov/pubmed/34756656
http://dx.doi.org/10.1016/j.bjps.2021.09.007
work_keys_str_mv AT howeiguang microsurgicalautologousbreastreconstructioninthemidstofapandemicasingleunitcovid19experience
AT kohlerguido microsurgicalautologousbreastreconstructioninthemidstofapandemicasingleunitcovid19experience
AT haywoodrichardm microsurgicalautologousbreastreconstructioninthemidstofapandemicasingleunitcovid19experience
AT rosichmedinaanais microsurgicalautologousbreastreconstructioninthemidstofapandemicasingleunitcovid19experience
AT masuddhalia microsurgicalautologousbreastreconstructioninthemidstofapandemicasingleunitcovid19experience